Ethyl 3-{3-t-butyl-5-[3-(4-chlorophenyl)ureido]-1h-pyrazol-1-yl}benzoate → 1-{5-t-Butyl-2-[3-(1-hydroxy-1-methyl-ethyl)-phenyl]-2h-pyrazol-3-yl}-3-(4-chloro-phenyl)-urea

Beteiligte Stoffe

Reaktionsschritte

To a solution of Example C. (220 mg, 0.5 mmol) in dry THF (20 mL) was added dropwise a solution of methyl magnesium bromide in toluene/THF (3.6 mL, 5.0 mmol) at −78° C. under N2. After stirring for 1 h, the mixture was allowed to rise to RT and stirred for another 2 h. The reaction mixture was quenched with saturated NH4Cl and aqueous HCl solution (10%), and extracted with ethyl acetate. The combined organic extracts were washed with brine, dried (Na2SO4), the solvent was removed in vacuo and the residue was purified by column chromatography to afford 1-{5-t-butyl-2-[3-(1-hydroxy-1-methyl-ethyl)-phenyl]-2H-pyrazol-3-yl}-3-(4-chloro-phenyl)-urea (174 mg, 81%). 1H NMR (DMSO-d6): 9.11 (s, 1 H), 8.34 (s, 1 H), 7.59 (s, 1H), 7.46 (t, J=8.8 Hz, 1 H), 7.43-7.40 (m, 3 H), 7.31-7.28 (m, 3 H), 6.34 (s, 1 H), 5.13 (s, 1 H), 1.42 (s, 6H), 1.27 (s, 9 H); MS (ESI) m/z: 428 (M+H+).

Herkunft & Nachweise